FindTrial
Sign In

Multi-center Randomized Double-blind Controlled Clinical Trial of Liu Jiaxiang's Qiyin Syndrome Granules in Preventing and Treating the Recurrence and Metastasis of Stage IIIA Non-small Cell Lung Cancer after Radical Operation

Multi-center Randomized Double-blind Controlled Clinical Trial of Liu Jiaxiang's Qiyin Syndrome Granules in Preventing and Treating the Recurrence and Metastasis of Stage IIIA Non-small Cell Lung Cancer after Radical Operation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018071
Enrollment
Unknown
Registered
2018-08-29
Start date
2018-11-15
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

experimental group:
control group:

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with complete resection who are at TNM stage IIIa, postoperative pathology confirmed for non-small cell lung cancer; (2) Patients who have completed standard adjuvant therapy after surgery; (3) Aged 18-75 years old; (4) Eastern Cooperative Oncology Group (ECOG) PS of three or less; (5) Blood routine ,liver and kidney function is basically normal; (6) Patients compliance is good, and patients can understand the situation of this study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) expected lifetime < 6 months; (2) there is no clear pathological diagnosis; (3) patients with intentional liver, kidney and hematopoietic diseases; (4) patients with pregnancy or lactation; (5) patients with hisory of serirous mental illness.

Design outcomes

Primary

MeasureTime frame
disease free survival;—

Secondary

MeasureTime frame
2-year disease-free survival rate;Quality of life;symptoms lists questionnaire of traditional Chinese medicine;overall survival;—

Countries

China

Contacts

Public ContactLingshuang Liu

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

liuls107@163.com+86 13818510253

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026